ProMIS Neurosciences Announces July 28 Webinar To Discuss Six-Month Blinded Interim Data From PMN310 PRECISE-AD Phase 1b Trial In Early Alzheimer's

뉴스 본문을 불러오고 있어요.

ProMIS Neurosciences Announces July 28 Webinar To Discuss Six-Month Blinded Interim Data From PMN310 PRECISE-AD Phase 1b Trial In Early Alzheimer's | 웨이프 WAPE

ProMIS Neurosciences Announces July 28 Webinar To Discuss Six-Month Blinded Interim Data From PMN310 PRECISE-AD Phase 1b Trial In Early Alzheimer's

기사 요약

관련 종목

댓글 —